Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDE225 in Early Stage ER-/HER2- Breast Cancer
NCT01757327Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2014
- Primary completion
- Dec 2016
- Modality
- Allosteric Modulators
01
Overview
A Phase 2 trial of sonidegib in breast cancer, sponsored by Washington University School of Medicine. Planned start Apr 2014; status: withdrawn.
02
Drugs
sonidegib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01757327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757327.